Smartphone-supported CGM a diabetes game changer
Pat is a 56-year-old accountant and avid horse rider who has type 1 diabetes. She self-presents to a local diabetes education clinic after years of…
Pat is a 56-year-old accountant and avid horse rider who has type 1 diabetes. She self-presents to a local diabetes education clinic after years of…
Leading endocrinologist Professor Jonathan Shaw was on holiday on K’gari (Fraser Island) off the coast of Queensland, with the patchy reception that entails, when he…
A leading endocrinologist has been the victim of a bizarre deepfake scam, with a news item fabricated by AI showing him describing doctors who prescribe…
New analyses of trial data suggest SGLT-2 inhibitors reduce incident diabetes in patients with cardiovascular or kidney disease, a team of international researchers says. Dapagliflozin…
GLP-1 receptor agonists offer significant renal protection as well as cardiovascular benefits, a meta-analysis shows. Australian-led research has found that patients taking the drugs have…
Type 2 diabetes treatments, such as low-calorie diets and bariatric surgery, can lead to remission for some patients, says new guidance from the RACGP and…
This 39-year-old pregnant woman had an unexpected reaction to her gestational diabetes treatment that resulted in distinct rashes on her abdomen and legs. She had…
Kaye is a 60-year-old woman with a highly demanding job as a CEO. She was diagnosed with type 1 diabetes at age 54 and started…
A study of postwar food rationing suggests that restricting exposure to sugar in early life staves off adult development of type 2 diabetes and hypertension,…
The TGA has approved empagliflozin for type 2 diabetes in children as young as 10, either combined with metformin or as monotherapy if metformin is…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.